+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

SLC20A2 variants cause dysfunctional phosphate transport activity in endothelial cells induced from Idiopathic Basal Ganglia Calcification patients-derived iPSCs



SLC20A2 variants cause dysfunctional phosphate transport activity in endothelial cells induced from Idiopathic Basal Ganglia Calcification patients-derived iPSCs



Biochemical and Biophysical Research Communications 2019



Idiopathic Basal Ganglia Calcification (IBGC) is a rare neuropsychiatric illness also known as Fahr's disease or Primary Familial Brain Calcification (PFBC). IBGC is caused by SLC20A2 variants, which encodes the inorganic phosphate (Pi) transporter PiT-2, a transmembrane protein associated with Pi homeostasis. We have reported novel SLC20A2 variants in the Japanese population and established an induced pluripotent stem cells (iPSCs) from an IBGC patient carrying a SLC20A2 variant. To investigate the effect of these SLC20A2 variants identified in our previous study, we used Chinese hamster ovary (CHO) cells expressing these variant proteins using the Flp-In system (Flp-In CHO cells), and showed that variant SLC20A2 proteins significantly disrupted the Pi transport activity in Flp-In CHO cells. Endothelial cells (ECs) represent important target cells for elucidating the pathology of IBGC. Using patient-derived iPSCs in this study, we differentiated these cells into ECs and found no significant difference in their differentiation capacity into ECs compared with control iPSCs. However, the Pi transport activity of IBGC patient-derived iPS-ECs was significantly decreased compared with that of control iPS-ECs without changing the gene expression of the other SLC 20 family members. We confirmed that SLC20A2 variants caused the loss of function of the Pi transport activity in both Flp-In CHO cells and disease-specific iPSCs. This is the first report to show an in vitro model of iPSCs in IBGC with patient-identified SLC20A2 variants. These useful tools will help in elucidating IBGC pathogenesis and can be used for screening drug candidates.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446817

Download citation: RISBibTeXText

PMID: 30704756

DOI: 10.1016/j.bbrc.2019.01.096


Related references

Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene. Stem Cell Research 24: 40-43, 2018

SLC20A2 Deficiency in Mice Leads to Elevated Phosphate Levels in Cerbrospinal Fluid and Glymphatic Pathway-Associated Arteriolar Calcification, and Recapitulates Human Idiopathic Basal Ganglia Calcification. Brain Pathology 27(1): 64-76, 2016

Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification. Gene 529(1): 159-162, 2013

A Novel SLC20A2 Mutation Associated with Familial Idiopathic Basal Ganglia Calcification and Analysis of the Genotype-Phenotype Association in Chinese Patients. Chinese Medical Journal 131(7): 799-803, 2018

Three novel missense mutations in SLC20A2 associated with idiopathic basal ganglia calcification. Journal of the Neurological Sciences 377: 62-64, 2017

Association between a novel mutation in SLC20A2 and familial idiopathic basal ganglia calcification. Plos One 8(2): E57060, 2013

Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics 14(1): 11-22, 2013

Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan. Neurology 82(8): 705-712, 2014

Inorganic phosphorus (Pi) in CSF is a biomarker for SLC20A2-associated idiopathic basal ganglia calcification (IBGC1). Journal of the Neurological Sciences 388: 150-154, 2018

Overall mutational spectrum of SLC20A2, PDGFB and PDGFRB in idiopathic basal ganglia calcification. Neurogenetics 15(3): 215-216, 2015

Reporting a new mutation at the SLC20A2 gene in familial idiopathic basal ganglia calcification. European Journal of Neurology 20(3): E43-E44, 2013

Mutation Analysis of SLC20A2 and SPP2 as Candidate Genes for Familial Idiopathic Basal Ganglia Calcification. Avicenna Journal of Medical Biotechnology 5(4): 251-256, 2013

Reporting a new mutation at the SLC20A2 gene in a Brazilian family with idiopathic basal ganglia calcification - Correction. European Journal of Neurology 20(9): E117-E117, 2013

Familial idiopathic basal ganglia calcification: Histopathologic features of an autopsied patient with an SLC20A2 mutation. Neuropathology 36(4): 365-371, 2017

Clinical features of familial idiopathic basal ganglia calcification caused by a novel mutation in the SLC20A2 gene. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 32(1): 64-68, 2015